The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors.

MLA

Khateb, Ali, et al. “The Ubiquitin Ligase RNF5 Determines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors.” Nature Communications, vol. 12, no. 1, Sept. 2021, p. 5397. EBSCOhost, https://doi.org/10.1038/s41467-021-25664-7.

APA

Khateb, A., Deshpande, A., Feng, Y., Finlay, D., Lee, J. S., Lazar, I., Fabre, B., Li, Y., Fujita, Y., Zhang, T., Yin, J., Pass, I., Livneh, I., Jeremias, I., Burian, C., Mason, J. R., Almog, R., Horesh, N., Ofran, Y., … Ronai, Z. A. (2021). The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. Nature Communications, 12(1), 5397. https://doi.org/10.1038/s41467-021-25664-7

Chicago

Khateb, Ali, Anagha Deshpande, Yongmei Feng, Darren Finlay, Joo Sang Lee, Ikrame Lazar, Bertrand Fabre, et al. 2021. “The Ubiquitin Ligase RNF5 Determines Acute Myeloid Leukemia Growth and Susceptibility to Histone Deacetylase Inhibitors.” Nature Communications 12 (1): 5397. doi:10.1038/s41467-021-25664-7.